Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 12/20 | 0.55 |
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | F11 | P03951 | 2/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | P4HB | P07237 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29738114 | 0.94 | LPL (0.51) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL12260788 | 0.89 | MAPK1 (0.50) | LPLLIPGCA2CA9CA12 | |
| SCHEMBL12292077 | 0.85 | LPL (0.58) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL228212 | 0.84 | LPL (0.71) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL12468077 | 0.84 | LIPG (0.55) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL30018822 | 0.82 | LIPG (0.56) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL22120102 | 0.82 | LPL (0.50) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL22191196 | 0.82 | LPL (0.56) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL15222374 | 0.80 | LIPG (0.67) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL20783855 | 0.80 | LIPG (0.47) | LPLLIPGCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874748-A | Aza-BODIPY base molecule with H aggregation induction and preparation method and application thereof | 南京工业大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119823065-A | Preparation method and application of dehydroabietyl D-A type polar response fluorescent compound | 南京林业大学 | 2025-04-15 | — | — | CN | claimed |
| CN-118085847-A | Tetraphenyl ethylene molecular composite material for beta-amyloid imaging and photodynamic oxidation | 北京化工大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117903157-A | Novel small molecular fluorescent probe for visualizing polar-viscosity sensitive lipid droplets, preparation method and application thereof | 齐鲁工业大学(山东省科学院) | 2024-04-19 | — | — | CN | claimed |
| CN-117682984-A | AIE active photosensitizer and preparation method and application thereof | 兰州大学 | 2024-03-12 | — | — | CN | claimed |
| CN-117209651-A | Photo-crosslinking polymerization processing electrochromic polymer, preparation method and application thereof | 浙江工业大学 | 2023-12-12 | — | — | CN | claimed |
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-31 | — | — | US | disclosed |
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | ORSOBIO INC (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4682146-A1 | COMPOSITION INCLUDING NOVEL PYRIDOINDOLE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES | Neurotarge Co., Ltd. (KR) | 2026-01-21 | — | — | EP | disclosed |
| EP-4674852-A1 | PREPARATION METHOD FOR AND USE OF DIHYDROTHIENOPYRIMIDINE DERIVATIVE | Innovstone Therapeutics Limited (CN) | 2026-01-07 | — | — | EP | disclosed |
| US-12409238-B2 | Silicone-based dyes with short wavelength infrared absorption and emission and methods for making and using the same | UNIV MISSISSIPPI (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250230169-A1 | Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding Moiety | CURIS INC (US) | 2025-07-17 | — | — | US | disclosed |
| CN-120202193-A | Chiral photosensitive molecular switch, cholesteric liquid crystal composition, display panel and preparation method of chiral photosensitive molecular switch and cholesteric liquid crystal composition | 京东方科技集团股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-100491323-C | Biaryloxymethylarenecarboxylic acids compound | HOFFMANN LA ROCHE (CH) | 2009-05-27 | — | — | CN | disclosed |
| US-20090124620-A1 | PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR | RENASCIENCE CO., LTD. (JP) | 2009-05-14 | — | — | US | disclosed |
| US-20080261988-A1 | IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS | SUPERGEN, INC. (US) | 2008-10-23 | — | — | US | disclosed |
| US-20080261988-A1 | IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS | SUPERGEN, INC. (US) | 2008-10-23 | — | — | US | disclosed |
| WO-2008058126-A2 | IMIDAZO[1,2-B]PYRIDAZINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS | SUPERGEN, INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| EP-1663936-B1 | BIARYLOXYMETHYLARENE-CARBOXYLIC ACIDS | HOFFMANN LA ROCHE (CH) | 2008-01-09 | — | — | EP | disclosed |
| CN-1812956-A | Biaryloxymethylarenecarboxylic acids as glycogen synthase activator | HOFFMANN LA ROCHE (CH) | 2006-08-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | CPT1B, CBR1, MUSK | LPL 299/4885LIPG 155/4885CA1 1765/4885 |
| US-20250230169-A1 | Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding Moiety | BAZ2A, BAZ2B, PI4KB | LPL 1525/4885LIPG 1712/4885CA1 2909/4885 |
| US-20080261988-A1 | IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS | PIM1, PIM2, PIM3 | LPL 4820/4885LIPG 4720/4885CA1 4535/4885 |
| US-20090124620-A1 | PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR | SERPINE1, SERPINC1, SERPINB1 | LPL 296/4885LIPG 416/4885CA1 1641/4885 |
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | ABL1, TH, CYP3A43 | LPL 4355/4885LIPG 4527/4885CA1 2908/4885 |
| US-12409238-B2 | Silicone-based dyes with short wavelength infrared absorption and emission and methods for making and using the same | SMARCB1, SMARCD1, SMARCA5 | LPL 2697/4885LIPG 2747/4885CA1 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.